3-n-butylphthalide has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZM; Li, PF; Liu, YQ; Mamun, AA; Wang, BN; Wang, J; Wu, CB; Wu, YQ; Xiao, J; Xiong, J; Xu, JY; Ye, LB; Zheng, PP; Zheng, ZL | 1 |
| Bai, XM; Ji, SX; Li, J; Yuan, F; Zhang, LH; Zhang, SY | 1 |
2 other study(ies) available for 3-n-butylphthalide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling and suppressing oxidative stress.
Topics: Animals; Apoptosis; Benzofurans; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Dendrites; Diabetes Mellitus, Type 2; Hippocampus; Male; Mice, Inbred C57BL; Morris Water Maze Test; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Synapses | 2021 |
L-3-n-butylphthalide attenuates cognitive deficits in db/db diabetic mice.
Topics: Animals; Benzofurans; Caspase 3; Cognition; Cognitive Dysfunction; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Hippocampus; Maze Learning; Mice; Neuroprotective Agents; Oxidative Stress | 2019 |